5,280 research outputs found

    Biotechnology portals in medicine

    Get PDF
    The 2005 global revenues of publicly traded biotechnology companies have grown by 18.1% to $63.1 billion (Donn, 2006). Many countries are now investing in research and development in the biotechnology industry as it is believed this 30 year-old industry is moving toward profitability. The stock value in this industry has outperformed the average stock value in many countries. In the pre-genomic era, a typical life sciences company would have marketed diagnostic kits, assays, chemicals, measuring equipment, and research products to name a few. In the genomic era, a new range of products is marketed focusing on molecular medicine. Among these new products are bioinformatics software solutions, storage systems, biotechnology systems, and solutions researching into genes and proteins, tools for analysis of genetic sequence data, integrated systems and solutions for disease research, and new drug discovery (Cader, 2004). The need for biotechnology portals is now more than justified and will be a useful information and knowledge source. A biotechnology portal is a gateway of comprehensive source of information and knowledge to those interested in knowing about biotechnology and the benefits this industry is offering. It should be considered as the first point of reference for those seeking reliable, quality, and current information and knowledge about issues in biotechnology. In addition, it should be interactive and have the appropriate tools to enable a community of users to share information and knowledge among them. There should also be a commercial component to the biotechnology portal, which should be to generate revenue through advertisements and offers to its target visitors. This revenue is essential to ensure the maintenance and survival of the portal and offer value to all its stakeholders. A biotechnology portal will not be complete unless it provides information on biotechnology stocks to potential investors seeking insights into this industry. A biotechnology portal is like any online business with various objectives such as profits, growth, market share, and innovation

    Encyclopedia of Portal Technologies and Applications - Biotechnology Portals in Medicine

    Get PDF
    The 2005 global revenues of publicly traded biotechnology companies have grown by 18.1% to $63.1 billion (Donn, 2006). Many countries are now investing in research and development in the biotechnology industry as it is believed this 30 year-old industry is moving toward profitability. The stock value in this industry has outperformed the average stock value in many countries. In the pre-genomic era, a typical life sciences company would have marketed diagnostic kits, assays, chemicals, measuring equipment, and research products to name a few. In the genomic era, a new range of products is marketed focusing on molecular medicine. Among these new products are bioinformatics software solutions, storage systems, biotechnology systems, and solutions researching into genes and proteins, tools for analysis of genetic sequence data, integrated systems and solutions for disease research, and new drug discovery (Cader, 2004). The need for biotechnology portals is now more than justified and will be a useful information and knowledge source

    What is eHealth?

    Get PDF
    Non utile per esam

    Horizons and Perspectives eHealth

    Get PDF
    EHealth platform represents the combined use of IT technologies and electronic communications in the health field, using data (electronically transmitted, stored and accessed) with a clinical, educational and administrative purpose, both locally and distantly. eHealth has the significant capability to increase the movement in the direction of services centered towards citizens, improving the quality of the medical act, integrating the application of Medical Informatics (Medical IT), Telemedicine, Health Telematics, Telehealth, Biomedical engineering and Bioinformatics. Supporting the creation, development and recognition of a specific eHealth zone, the European Union policies develop through its programs FP6 and FP7, European-scale projects in the medical information technologies (the electronic health cards, online medical care, medical web portals, trans-European nets for medical information, biotechnology, generic instruments and medical technologies for health, ICT mobile systems for remote monitoring). The medical applications like electronic health cards ePrescription, eServices, medical eLearning, eSupervision, eAdministration are integral part of what is the new medical branch-eHealth, being in a continuous expansion due to the support from the global political, financial and medical organizations; the degree of implementation of the eHealth platform varying according to the development level of the communication infrastructure, allocated funds, intensive political priorities and governmental organizations opened to the new IT challenges.eHealth, telemedicine, telehealth, bioinformatics, telematics

    Bioethics: Reincarnation of Natural Philosophy in Modern Science

    Get PDF
    The theory of evolution of complex and comprising of human systems and algorithm for its constructing are the synthesis of evolutionary epistemology, philosophical anthropology and concrete scientific empirical basis in modern (transdisciplinary) science. «Trans-disciplinary» in the context is interpreted as a completely new epistemological situation, which is fraught with the initiation of a civilizational crisis. Philosophy and ideology of technogenic civilization is based on the possibility of unambiguous demarcation of public value and descriptive scientific discourses (1), and the object and subject of the cognitive process (2). Both of these attributes are no longer valid. For mass, everyday consciousness and institutional philosophical tradition it is intuitively obvious that having the ability to control the evolutionary process, Homo sapiens came close to the borders of their own biological and cultural identity. The spontaneous coevolutionary process of interaction between the «subject» (rational living organisms) and the «object» (material world), is the teleological trend of the movement towards the complete rationalization of the World as It Is, its merger with the World of Due. The stratification of the global evolutionary process into selective and semantic (teleological) coevolutionary and therefore ontologically inseparable components follows. With the entry of anthropogenic civilization into the stage of the information society, firsty, the post-academic phase of the historical evolution of scientific rationality began, the attributes of which are the specific methodology of scientific knowledge, scientific ethos and ontology. Bioethics as a phenomenon of intellectual culture represents a natural philosophical core of modern post- academic (human-dimensional) science, in which the ethical neutrality of scientific theory principle is inapplicable, and elements of public-axiological and scientific-descriptive discourses are integrated into a single logic construction. As result, hermeneutics precedes epistemology not only methodologically, but also meaningfully, and natural philosophy is regaining the status of the backbone of the theory of evolution – in an explicit for

    Download the PDF of the full issue

    Get PDF

    Topics of Bioengineering in Wikipedia

    Get PDF
    The present report aims to give a snapshot of how topics from the field of bioengineering (bioinformatics, bioprocess systems, biomedical engineering, biotechnology, etc.) are currently covered in the free electronic encyclopedia Wikipedia. It also offers insights and information about what Wikipedia is, how it functions, how and when to cite Wikipedian articles, if necessary. Several external wikis, devoted to topics of bioengineering, are also listed and reviewed

    Raising the visibility of protected data: A pilot data catalog project

    Get PDF
    Sharing research data that is protected for legal, regulatory, or contractual reasons can be challenging and current mechanisms for doing so may act as barriers to researchers and discourage data sharing. Additionally, the infrastructure commonly used for open data repositories does not easily support responsible sharing of protected data. This chapter presents a case study of an academic university library’s work to configure the existing institutional data repository to function as a data catalog. By engaging in this project, university librarians strive to enhance visibility and access to protected datasets produced at the institution and cultivate a data sharing culture
    • …
    corecore